Open-Label Safety Study of ADS-5102 in PD Patients With LID (Q65353592)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Open-Label Safety Study of ADS-5102 in PD Patients With LID |
clinical trial |
Statements
Open-Label Safety Study of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia (LID) (English)
0 references
July 2014
0 references
March 2018
0 references
250
0 references
30 year
0 references
85 year
0 references